JDSupra: 340B Covered Entities Beware: CMS Proposes Drastic Drug Reimbursement Rate Cuts | 340B Matters
16412
post-template-default,single,single-post,postid-16412,single-format-standard,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

17 Aug JDSupra: 340B Covered Entities Beware: CMS Proposes Drastic Drug Reimbursement Rate Cuts

“In its Outpatient Prospective Payment System proposed rule (“Proposed Rule”), CMS outlined a significant Medicare Part B payment reduction for separately payable, nonpassthrough drugs provided in the hospital outpatient settings. You can find the Proposed Rule here. The proposal comes at a time when 340B stakeholders continue to face pressure to increase audit and program integrity efforts. Here are five things you should know about CMS’s Proposed Rule:”

Read more: http://www.jdsupra.com/legalnews/340b-covered-entities-beware-cms-43488/

 

 

Want To Stay Up-To-Date On The Latest 340B News?